Malignant Thyroid Gland Neoplasm — Trials

Malignant Thyroid Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

790 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 176
Recruiting: 92
Ph III recruiting: 12
Growth YoY: +4.9%
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.9%
Trials / 1,000 deaths: 81.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (65)

clinicaltrialsPublishedShowing 51–100 of 150 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07376837	Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study(PTC-RFA)	recruiting	N/A	30	University Health Network, TorontoOTHER	1	May 19, 2026	clinicaltrials
NCT06673329	Brodalumab in the Treatment of Immune-Related Adverse Events	recruiting	Phase 1	11	Brian Henick, MDOTHER	1	May 13, 2026	clinicaltrials